|
Name |
Catalponol
|
Molecular Formula | C15H18O2 | |
IUPAC Name* |
(2R,4S)-4-hydroxy-2-(3-methylbut-2-enyl)-3,4-dihydro-2H-naphthalen-1-one
|
|
SMILES |
CC(=CC[C@@H]1C[C@@H](C2=CC=CC=C2C1=O)O)C
|
|
InChI |
InChI=1S/C15H18O2/c1-10(2)7-8-11-9-14(16)12-5-3-4-6-13(12)15(11)17/h3-7,11,14,16H,8-9H2,1-2H3/t11-,14+/m1/s1
|
|
InChIKey |
BTQXIESSQVRLCV-RISCZKNCSA-N
|
|
Synonyms |
Catalponol; 34168-56-4; (2R,4S)-4-hydroxy-2-(3-methylbut-2-enyl)-3,4-dihydro-2H-naphthalen-1-one; 1(2H)-Naphthalenone,3,4-dihydro-4-hydroxy- 2-(3-methyl-2-butenyl)-,(2R,4S)-; CHEMBL496250; DTXSID70187771; HY-N3550; ZINC5158854; AKOS032948764; CS-0023818; (3R,4S)-4-Hydroxy-3-(2'-isopentenyl)-1,2,3,4-tetrahydronaphthalen-1-one; 2alpha-(3-Methyl-2-butenyl)-4alpha-hydroxy-1,2,3,4-tetrahydronaphthalene-1-one
|
|
CAS | 34168-56-4 | |
PubChem CID | 169570 | |
ChEMBL ID | CHEMBL496250 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 230.3 | ALogp: | 2.9 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 2 |
Heavy Atoms: | 17 | QED Weighted: | 0.778 |
Caco-2 Permeability: | -4.552 | MDCK Permeability: | 0.00002460 |
Pgp-inhibitor: | 0.038 | Pgp-substrate: | 0.176 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.069 |
30% Bioavailability (F30%): | 0.619 |
Blood-Brain-Barrier Penetration (BBB): | 0.746 | Plasma Protein Binding (PPB): | 93.22% |
Volume Distribution (VD): | 1.452 | Fu: | 5.85% |
CYP1A2-inhibitor: | 0.719 | CYP1A2-substrate: | 0.542 |
CYP2C19-inhibitor: | 0.745 | CYP2C19-substrate: | 0.68 |
CYP2C9-inhibitor: | 0.269 | CYP2C9-substrate: | 0.884 |
CYP2D6-inhibitor: | 0.037 | CYP2D6-substrate: | 0.5 |
CYP3A4-inhibitor: | 0.115 | CYP3A4-substrate: | 0.366 |
Clearance (CL): | 12.031 | Half-life (T1/2): | 0.157 |
hERG Blockers: | 0.055 | Human Hepatotoxicity (H-HT): | 0.774 |
Drug-inuced Liver Injury (DILI): | 0.141 | AMES Toxicity: | 0.159 |
Rat Oral Acute Toxicity: | 0.376 | Maximum Recommended Daily Dose: | 0.927 |
Skin Sensitization: | 0.144 | Carcinogencity: | 0.461 |
Eye Corrosion: | 0.008 | Eye Irritation: | 0.486 |
Respiratory Toxicity: | 0.767 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000973 | 0.593 | D04QZD | 0.278 | ||||
ENC006142 | 0.446 | D03GET | 0.277 | ||||
ENC004793 | 0.397 | D0W6DG | 0.265 | ||||
ENC001031 | 0.393 | D06BYV | 0.265 | ||||
ENC006049 | 0.371 | D0GY5Z | 0.262 | ||||
ENC006048 | 0.371 | D08EOD | 0.257 | ||||
ENC001083 | 0.349 | D0T3NY | 0.257 | ||||
ENC004861 | 0.338 | D0R8PX | 0.257 | ||||
ENC004862 | 0.333 | D01PZD | 0.256 | ||||
ENC005244 | 0.328 | D07HBX | 0.254 |